|
21.
|
|
7 p, 530.8 KB |
Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT
/
Sheth, Vipul (Fred Hutchison Cancer Research Centre) ;
Volt, Fernanda (Eurocord) ;
Sanz, Jaime (Hospital Universitari i Politècnic La Fe (València)) ;
Clement, Laurence (Haut-Lévêque) ;
Cornelissen, Jan (Erasmus MC-Daniel den Hoed Cancer Centre) ;
Blaise, Didier (Paoli Calmettes) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Michallet, Mauricette (Centre Leon Berard) ;
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Rocha, Vanderson (Eurocord) ;
Gluckman, Eliane (Eurocord) ;
Chabannon, Christian (Institut Paoli-Calmettes) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Universitat Autònoma de Barcelona
The use of myeloablative conditioning (MAC) in umbilical cord blood transplantation (UCBT) has been associated with high nonrelapse mortality (NRM) in patients aged >40 years, especially those having a high HLA disparity, thus limiting wider applications. [...]
2020 -  10.1016/j.bbmt.2020.07.025
Biology of blood and marrow transplantation, Vol. 26 Núm. 11 (november 2020) , p. 2098-2104
|
|
|
22.
|
|
7 p, 473.0 KB |
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
/
Penack, Olaf (Charité - Universitätsmedizin Berlin) ;
Peczynski, Christophe (EBMT Statistical Unit) ;
van der Werf, Steffie (EBMT Data Office) ;
Finke, Jürgen (University of Freiburg) ;
Ganser, Arnold (Hannover Medical School) ;
Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ;
Pavlu, Jiri (Imperial College London) ;
Niittyvuopio, Riitta. (HUCH Comprehensive Cancer Center) ;
Schroyens, Wilfried (University Hospital Antwerp (Bèlgica)) ;
Kaynar, Leylagül (Erciyes University Medical Faculty) ;
Blau, Igor W. (Charité - Universitätsmedizin Berlin) ;
van der Velden, Walter (Radboud University - Nijmegen Medical Centre) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Cortelezzi, Agostino (Fondazione IRCCS - Ca'Granda) ;
Wulf, Gerald (Universitätsklinikum Göttingen) ;
Turlure, Pascal (CHRU Limoges) ;
Rovira, Montserrat (Hospital Clínic i Provincial de Barcelona) ;
Ozkurt, Zubeydenur (Gazi University) ;
Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ;
Moreira, Maria C. (Instituto National do Cancer) ;
Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ;
Greinix, Hildegard (LKH - University Hospital Graz) ;
Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Basak, Grzegorz (Medical University of Warsaw) ;
Universitat Autònoma de Barcelona
ric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-versus-host disease (GvHD). [...]
2020 - 10.3324/haematol.2019.228668
Haematologica, Vol. 105 Núm. 7 (january 2020) , p. 1977-1983
|
|
|
23.
|
|
8 p, 3.0 MB |
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
/
Penack, Olaf (Charité - Universitätsmedizin Berlin) ;
Peczynski, Christophe (EBMT Statistical Unit) ;
van der Werf, Steffie (EBMT Data Office) ;
Finke, Jürgen (University of Freiburg) ;
Ganser, Arnold (Hannover Medical School) ;
Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ;
Pavlu, Jiri (Imperial College London) ;
Niittyvuopio, Riitta (HUCH Comprehensive Cancer Center) ;
Schroyens, W.ilfried (University Hospital Antwerp (Bèlgica)) ;
Kaynar, Leylagül (Erciyes University) ;
Blau, Igor W. (Department of Hematology. Oncology. and Tumor Immunology) ;
van der Velden, Walter J.F.M. (Radboud University) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Cortelezzi, Agostini (University of Milan) ;
Wulf, Gerald (Universitätsklinikum Göttingen) ;
Turlure, Pascal (CHRU Limoges) ;
Rovira Argelagués, Montserrat (Hospital Clínic i Provincial de Barcelona) ;
Ozkurt, Zubeydenur (Gazi University) ;
Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ;
Moreira, Maria C. (Instituto National do Cancer) ;
Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ;
Greinix, Hildegard (Medical University of Graz) ;
Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Basak, Grzegorz (Medical University of Warsaw) ;
Universitat Autònoma de Barcelona
Elevated serum ferritin levels occur due to iron overload or during inflammation and macrophage activation. A correlation of high serum ferritin levels with increased mortality after alloSCT has been suggested by several retrospective analyses as well as by two smaller prospective studies. [...]
2020 - 10.3389/fimmu.2020.00586
Frontiers in immunology, Vol. 11 (15 2020) , p. 586
|
|
|
24.
|
|
8 p, 930.0 KB |
Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study
/
Escamilla Gómez, Virginia (Universidad de Sevilla) ;
García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ;
López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ;
Márquez Malaver, Francisco J. (Universidad de Sevilla) ;
Caballero Velazquez, Teresa (Universidad de Sevilla) ;
González Sierra, Pedro A. (Hospital Universitario (Granada)) ;
Viguria Alegría, María C. (Complejo Hospitalario de Navarra) ;
Parra Salinas, Ingrid M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Calderón Cabrera, Cristina (Universidad de Sevilla) ;
González Vicent, Marta (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Rodríguez Torres, Nancy (Universidad de Sevilla) ;
Parody Porras, Rocío (Instituto Catalá de Oncología Hospitalet) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Orti, Guillermo (Hospital Universitari Vall d'Hebron) ;
Valcárcel Ferreiras, David (Hospital Universitari Vall d'Hebron) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Molés, Paula (Hospital Universitari i Politècnic La Fe (València)) ;
Velázquez-Kennedy, Kyra (Hospital Universitari Ramon y Cajal) ;
João Mende, María (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Caballero Barrigón, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Saavedra Gerosa, Silvanna (Institut d'Investigació Biomèdica Sant Pau) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Poch, Marc (Clinic Hospital Universitari de Valencia) ;
Zudaire Ripa, María T. (Complejo Hospitalario de Navarra) ;
Díaz Pérez, Miguel A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Molina Angulo, Blanca (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Sánchez Ortega, Isabel (Instituto Catalá de Oncología Hospitalet) ;
Sanz Caballer, Jaime (Hospital Universitari i Politècnic La Fe (València)) ;
Montoro Gómez, Juan (Hospital Universitari i Politècnic La Fe (València)) ;
Espigado Tocino, Ildefonso (Universidad de Sevilla) ;
Pérez-Simón, José A. (Universidad de Sevilla) ;
Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648
|
|
|
25.
|
|
33 p, 2.0 MB |
Diagnosis and management of AML in adults : 2022 recommendations from an international expert panel on behalf of the ELN
/
Döhner, Hartmut (Ulm University Hospital. Department of Internal Medicine III) ;
Wei, Andrew H. (Peter MacCallum Cancer Centre. Royal Melbourne Hospital and University of Melbourne. Department of Haematology) ;
Appelbaum, Frederick (University of Washington. Fred Hutchinson Cancer Research Center) ;
Craddock, Charles (Centre for Clinical Haematology. Queen Elizabeth Hospital. University of Birminham) ;
DiNardo, Courtney D. (The University of Texas MD Anderson Cancer Center. Department of Leukemia) ;
Dombret, Hervé (Saint-Louis Institute for Research. Université de Paris. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris. Department of Hematology) ;
Ebert, Benjamin L. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Fenaux, Pierre (Service d'Hématologie Séniors. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris) ;
Godley, Lucy A. (The University of Chicago. Section of Hematology/Oncology. Department of Medicine) ;
Hasserjian, Robert P (Massachusetts General Hospital (Boston)) ;
Larson, Richard A (University of Chicago. Department of Medicine and Comprehensive Cancer Center) ;
Levine, Ross L. (Memorial Sloan Kettering Cancer Center. Human Oncology and Pathogenesis Program and Leukemia Service. Department of Medicine) ;
Miyazaki, Yasushi (Atomic Bomb Disease Institute. Nagasaki University. Department of Hematology) ;
Niederwieser, Dietger (University of Leipzig) ;
Ossenkoppele, Gert (Department of Haematology. Amsterdam UMC. Location VU University Medical Center) ;
Röllig, Christoph (Department of Internal Medicine I. University Hospital Carl Gustav Carus TU Dresden) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Stein, Eytan M. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ;
Tallman, Martin S. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ;
Tien, Hwei-Fang F. (Division of Hematology. Department of Internal Medicine. National Taiwan University Hospital) ;
Wang, Jianxiang (Institute of Hematology and Blood Diseases Hospital. Chinese Academy of Medical Sciences & Peking Union Medical College) ;
Wierzbowska, Agnieszka (Department of Hematology. Medical University of Lodz) ;
Löwenberg, Bob (Department of Hematology. Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute)
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. [...]
2022 - 10.1182/blood.2022016867
Blood, Vol. 140 Núm. 12 (september 2022) , p. 1345-1377
|
|
|
26.
|
|
17 p, 7.3 MB |
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
/
Núñez, Yáiza (Institut d'Investigació Biomèdica Sant Pau) ;
Garcia-León, Annabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Falgàs, Aïda (Institut d'Investigació Biomèdica Sant Pau) ;
Serna, Naroa (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ;
Sánchez-García, Laura (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Garrido, Ana (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sierra, Jorge (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Gallardo, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Unzueta Elorza, Ugutz (Institut d'Investigació Biomèdica Sant Pau) ;
Vázquez Gómez, Esther (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ;
Villaverde Corrales, Antonio (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ;
Mangues, Ramon 1957- (Institut d'Investigació Biomèdica Sant Pau) ;
Casanova Rigat, Isolda (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Despite advances in the development of targeted therapies for acute myeloid leukemia (AML), most patients relapse. For that reason, it is still necessary to develop novel therapies that improve treatment effectiveness and overcome drug resistance. [...]
2023 - 10.3390/pharmaceutics15030727
Pharmaceutics, Vol. 15, Issue 3 (March 2023) , art. 727
|
|
|
27.
|
|
9 p, 1.7 MB |
Survival improvement of patients with FLT3 mutated acute myeloid leukemia : results from a prospective 9 years cohort
/
Oñate, Guadalupe (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Pratcorona, Marta (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Garrido, Ana (Institut d'Investigació Biomèdica Sant Pau) ;
Artigas-Baleri, Alícia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Bataller, Alex (Hospital Clínic i Provincial de Barcelona) ;
Tormo, Mar (Instituto de Investigación Sanitaria (València)) ;
Arnan, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ;
Vives Polo, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Coll, Rosa (Institut Català d'Oncologia) ;
Salamero, Olga (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vall-Llovera, Ferran (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Garcia, Antoni (Hospital Arnau de Vilanova (València)) ;
Cervera, Marta (Institut Catala d'Oncologia) ;
Garcia-Avila, Sara (Hospital del Mar (Barcelona, Catalunya)) ;
Bargay, Joan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Ortín, Xavier (Hospital de Tortosa Verge de la Cinta) ;
Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Midostaurin added to intensive chemotherapy is the standard of care for acute myeloid leukemia (AML) with FLT3 mutations (FLT3 mut). We analyzed the impact of midostaurin in 227 FLT3 mut-AML patients included in the AML-12 prospective trial for fit patients ≤70 years (#NCT04687098). [...]
2023 - 10.1038/s41408-023-00839-1
Blood Cancer Journal, Vol. 13 (may 2023)
|
|
|
28.
|
|
14 p, 4.5 MB |
The potential of local food, energy, and water production systems on urban rooftops considering consumption patterns and urban morphology
/
Toboso-Chavero, Susana (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ;
Montealegre, Antonio Luis (Centro Universitario de la Defensa de Zaragoza) ;
García-Pérez, Sergio (Universidad de Zaragoza. Departamento de Arquitectura) ;
Sierra-Pérez, Jorge (Universidad de Zaragoza. Departamento de Ingeniería de Diseño y Fabricación) ;
Muñoz-Liesa, Joan (Universitat Politècnica de Catalunya. Departament d'Enginyeria Civil i Ambiental) ;
Gabarrell Durany, Xavier (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Villalba, Gara (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Madrid, Cristina (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
The external resource dependency of urban areas results in the externalization of environmental and socioeconomic impacts. Implementing food, energy and water production systems on urban rooftops (roof mosaics) can potentially help cities become more self-sufficient but depends on the city's urban morphology. [...]
2023 - 10.1016/j.scs.2023.104599
Sustainable Cities and Society, Vol. 95 (August 2023) , art. 104599
|
|
|
29.
|
|
15 p, 1.5 MB |
Environmental assessment of a new building envelope material derived from urban agriculture wastes : the case of the tomato plants stems
/
Llorach-Massana, Pere (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ;
Cirrincione, Laura (Università degli Studi di Palermo. Department of Engineering) ;
Sierra-Perez, Jorge (Universidad de Zaragoza. Departamento de Ingeniería de Diseño y Fabricación) ;
Scaccianoce, Gianluca (Università degli Studi di Palermo. Department of Engineering) ;
La Gennusa, Maria (Università degli Studi di Palermo. Department of Engineering) ;
Peña, Javier (Escola Universitària de Disseny i Enginyeria de Barcelona) ;
Rieradevall, Joan (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental)
Purpose: Decarbonizing cities is one of today's biggest challenges. In this regard, particular attention has been paid on improving the environmental performance of buildings. In this framework, this work consists in assessing the environmental impact of an innovative building envelope component derived from urban agriculture (UA) wastes. [...]
2023 - 10.1007/s11367-023-02152-2
The international journal of life cycle assessment, (March 2023)
|
|
|
30.
|
|
8 p, 440.5 KB |
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation : A Report on Behalf of the American Society for Transplantation and Cellular Therapy
/
Kharfan-Dabaja, Mohamed A. (Mayo Clinic. Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program) ;
Kumar, Ambuj (Program for Comparative Effectiveness Research. Morsani College of Medicine. University of South Florida) ;
Ayala, Ernesto (Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program. Mayo Clinic) ;
Aljurf, Mahmoud (Department of Adult Hematology and Stem Cell Transplantation. King Faisal Specialist Hospital and Research Centre) ;
Nishihori, Taiga (Department of Blood and Marrow Transplantation and Cellular Immunotherapy. Moffitt Cancer Center) ;
Marsh, Rebecca (Cincinnati Children's Hospital Medical Center) ;
Burroughs, Laura M. (Fred Hutchinson Cancer Research Center) ;
Majhail, Navneet (Blood and Marrow Transplant Program. Taussig Cancer Institute. Cleveland Clinic) ;
Al-Homsi, Ahmad Samer (NYU Langone Health) ;
Al-Kadhimi, Zaid S. (Division of Oncology and Hematology. Department of Internal Medicine. University of Nebraska Medical Center) ;
Bar, Merav (Fred Hutchinson Cancer Research Center) ;
Bertaina, Alice (Division of Stem Cell Transplant and Regenerative Medicine. Department of Pediatrics. Stanford University) ;
Boelens, Jaap Jan (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ;
Champlin, Richard (Department of Stem Cell Transplantation and Cellular Therapy. The University of Texas MD Anderson Cancer Center) ;
Chaudhury, Sonali (Ann and Robert H. Lurie Children's Hospital of Chicago) ;
DeFilipp, Zachariah (Massachusetts General Hospital (Boston)) ;
Dholaria, Bhagirathbhai (Vanderbilt University Medical Center) ;
El-Jawahri, Areej (Massachusetts General Hospital (Boston)) ;
Fanning, Suzanne (Blood and Marrow Transplant Program. University of South Carolina School of Medicine) ;
Fraint, Ellen (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ;
Gergis, Usama (Bone Marrow Transplant and Immune Cellular Therapy. Thomas Jefferson University Hospital) ;
Giralt, Sergio (Department of Medicine. Division of Hematologic Malignancies. Memorial Sloan Kettering Cancer Center Weill Cornell Medical College) ;
Hamilton, Betty K. (Blood and Marrow Transplant Program. Taussig Cancer Institute. Cleveland Clinic) ;
Hashmi, Shahrukh K (Department of Medicine. Sheikh Shakhbout Medical City) ;
Horn, Biljana (Department of Pediatrics. Division of Hematology/Oncology. University of Florida. UF Health Shands Children's Hospital) ;
Inamoto, Yoshihiro (National Cancer Center Hospital) ;
Jacobsohn, David A. (Children's National Medical Center) ;
Jain, Tania (Johns Hopkins University School of Medicine) ;
Johnston, Laura (Stanford University School of Medicine) ;
Kanate, Abraham S. (West Virginia University) ;
Kansagra, Ankit (UT Southwestern Medical Center) ;
Kassim, Adetola (Vanderbilt University Medical Center) ;
Kean, Leslie S. (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ;
Kitko, Carrie L. (Vanderbilt University Medical Center) ;
Knight-Perry, Jessica (University of Colorado School of Medicine) ;
Kurtzberg, Joanne (Duke University School of Medicine) ;
Liu, Hien (Moffitt Cancer Center) ;
MacMillan, Margaret L (University of Minnesota Medical School) ;
Mahmoudjafari, Zahra (University of Kansas Cancer Center) ;
Mielcarek, Marco (Fred Hutchinson Cancer Research Center) ;
Mohty, Mohamad (Sorbonne Université. INSERM. Centre de Recherche Saint-Antoine and Hôpital Saint-Antoine. Service d'Hématologie Clinique et Thérapie Cellulaire) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Nemecek, Eneida (Oregon Health & Science University) ;
Olson, Timothy S. (Children's Hospital of Philadelphia (Pennsilvània)) ;
Oran, Betul (The University of Texas MD Anderson Cancer Center) ;
Perales, Miguel Angel (Memorial Sloan Kettering Cancer Center Weill Cornell Medical College) ;
Prockop, Susan E. (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ;
Pulsipher, Michael A. (Children's Hospital Los Angeles Cancer and Blood Disease Institute. USC Keck School of Medicine) ;
Pusic, Iskra (Washington University School of Medicine) ;
Riches, Marcie L. (University of North Carolina at Chapel Hill) ;
Rodriguez, Cesar (Wake Forest University School of Medicine) ;
Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Rondon, Gabriela (The University of Texas MD Anderson Cancer Center) ;
Saad, Ayman (The Ohio State University. Division of Hematology) ;
Shah, Nina (University of California San Francisco. Department of Medicine) ;
Shaw, Peter J. (The Children's Hospital at Westmead) ;
Shenoy, Shalini (Washington University School of Medicine) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Talano, Julie (Children's Hospital of Wisconsin) ;
Verneris, Michael R. (University of Colorado School of Medicine) ;
Veys, Paul (University College London. Great Ormond Street Hospital.) ;
Wagner, John E. (University of Minnesota Medical School) ;
Savani, Bipin N. (Vanderbilt University Medical Center) ;
Hamadani, Mehdi (Medical College of Wisconsin) ;
Carpenter, Paul A. (Fred Hutchinson Cancer Research Center) ;
Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematologic malignancies and nonmalignant diseases. The field of allo-HCT has witnessed significant advances, including broadening indications for transplantation, availability of alternative donor sources, less toxic preparative regimens, new cell manipulation techniques, and novel GVHD prevention methods, all of which have expanded the applicability of the procedure. [...]
2021 - 10.1016/j.jtct.2021.04.007
Transplantation and Cellular Therapy, Vol. 27 Núm. 8 (august 2021) , p. 642-649
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
